Indeed, clinical trials using simvastatin for the treatment of NF1 have shown little promise, while trials with lovastatin show an improvement in cognitive deficits (van der Vaart et al., 2013; Bearden et al., 2016; Payne et al., 2016). This evidence concerns the gene NF1 and Cognitive impairment.